Skip to main content
Log in

Cardiacβ 2-adrenoceptors and the inotropic response to exercise in man

  • Research Paper
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract

To find out what role, if any,β 2-adrenoceptors play in cardiac contractility, the heart rate, stroke volume and cardiac output of twelve healthy male and female volunteers (aged 18–28 years) were studied at rest (standing) and during two stages of treadmill exercise, 2 h after ingestion of propranolol (100 mg) or atenolol (100 mg) or a placebo, on different occasions, in a double-blind crossover manner. Cardiac output was measured by a carbon dioxide—rebreathing method. Atenolol and propranolol caused equal reductions in heart rate at rest, and in heart rate and cardiac output during exercise (p < 0.001, two-way analysis of variance). Neither atenolol nor propranolol had any significant effect on resting cardiac output, resting stroke volume or stroke volume during exercise. Since atenolol (100 mg) has been shown to beβ 1-adrenoceptorselective, we conclude that cardiac inotropic function during exercise is largelyβ 1-adrenoceptor-mediated with little or noβ 2-adrenoceptor involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brodde OE. Cardiac beta-adrenoceptors.ISI Atlas Sci Pharmacol 1987;1: 107–112.

    Google Scholar 

  2. Brodde OE.β 1- andβ 2-adrenoceptors in the human heart: properties, function, and alteration in chronic heart failure.Pharmacol Rev 1991;43: 203–242.

    PubMed  Google Scholar 

  3. Kaumann AJ. Is there a third heartβ-adrenoceptor?Trends Pharmacol Sci 1989;10: 316–320.

    Google Scholar 

  4. Zaagsma J, Nahorski SR. Is the adipocyteβ-adrenoceptor a prototype for the recently cloned atypicalβ 3-adrenoceptor?Trends Pharmacol Sci 1990;125: 3–7.

    Google Scholar 

  5. Waller DG.β-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?Br J Clin Pharmacol 1990;30: 157–171.

    PubMed  Google Scholar 

  6. Fujimura A, Kumagai Y, Sugimoto K, Nakashima H, Kajiyama H, Ebihara A, Ohashi K. Circadian influence on effect of propranolol on exercise induced tachycardia in healthy subjects.Eur J Clin Pharmacol 1990;38: 133–137.

    PubMed  Google Scholar 

  7. Collier CR. Determination of mixed venous tentions by rebreathing.J Appl Physiol 1956;9: 25–29.

    PubMed  Google Scholar 

  8. Ashton CH, McHardy GJR. A rebreathing method for determining mixed venous Pco2 during exercise.J Appl Physiol 1963;18: 668–671.

    Google Scholar 

  9. Denison D. Mixed venous blood gas tensions and respiratory stress in man. PhD Thesis, Univ London, 1968.

  10. Zeidifard E, Silverman M, Godfrey S. Reproducibility of the indirect (CO2) Fick method for calculation of cardiac output.J Appl Physiol 1972;33: 141–143.

    PubMed  Google Scholar 

  11. Jones NL, Rebuck AS. Rebreathing of CO2 during exercise.J Appl Physiol 1973;35: 538–541.

    PubMed  Google Scholar 

  12. Muiesan G, Sorbini CA, Solinas E, Grassi V, Casucci G, Petz E. Comparison of CO2 rebreathing and direct Fick methods for determining cardiac output.J Appl Physiol 1968;24: 424–429.

    PubMed  Google Scholar 

  13. Reybrouck T, Amery A, Billiet L, Fagard R, Stijns H. Comparison of cardiac output determination by a carbon dioxide rebreathing and direct Fick method at rest and during exercise.Clin Sci Mol Med 1978;55: 445–452.

    PubMed  Google Scholar 

  14. Hamilton WF. The Lewis A. Connor memorial lecture. The physiology of cardiac output.Circulation 1953;8: 527–543.

    PubMed  Google Scholar 

  15. Robinson S, Pearcy M, Brueckman FR, Nicholas JR, Miller D. Effects of atropine on heart rate and oxygen intake in working man.J Appl Physiol 1953;5: 508–512.

    PubMed  Google Scholar 

  16. Robinson BF, Epstein SE, Beiser CD, Braunwald E. Control of heart rate by the autonomic nervous system. Studies in man on the inter-relation between baroreceptor mechanisms and exercise.Circ Res 1966;19: 400–411.

    PubMed  Google Scholar 

  17. Christensen NJ, Galbo H, Hansen JF, Hesse B, Richtert EA, Trap-Jensen J. Catecholamines and exercise.Diabetes 1979;28(S1): 58–62.

    PubMed  Google Scholar 

  18. Price HL. Circulating adrenaline and noradrenaline during diethylether anaesthesia.Clin Sci 1957;16: 377–387.

    PubMed  Google Scholar 

  19. Robertson D, Garland A, Johnson GA, Robertson RM, Nies AS, Shand D, Oakes JA. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.Circulation 1979;59: 637–643.

    PubMed  Google Scholar 

  20. Friedman DB, Ordway GA, Williams RS. Exercise-induced functional desensitization of canine cardiacβ-adrenoceptors.J Appl Physiol 1987;62: 1721–1723.

    PubMed  Google Scholar 

  21. Fitzgerald JD, Gumbrielle T, Harry JD. Effects in man of ICI 118551 (A selectiveβ 2-adrenoceptor blocking drug) on some cardiovascular responses induced by isoprenaline.Br J Clin Pharmacol 1981;13: 586P.

  22. Hespel P, Lijnen P, Vanhees L, Fagard R, Amery A. Betaadrenoceptors and the regulation of BP and plasma renin during exercise.J Appl Physiol 1986;60: 108–113.

    PubMed  Google Scholar 

  23. Jefferson D, Wharrad HJ, Birmingham AT, Patrick JM. The comparative effects of ICI 118551 and propranolol on essential tremor.Br J Clin Pharmacol 1987;24: 729–734.

    PubMed  Google Scholar 

  24. Pringle TH, Riddell JG, Shanks RG. Characterization of the beta-adrenoceptors which mediate the isoprenaline-induced changes in finger tremor and cardiovascular function in man.Eur J Clin Pharmacol 1988;35: 507–514.

    PubMed  Google Scholar 

  25. Cleeves L, Findley LJ. Beta-adrenoceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoceptor antagonist.J Neurol Neurosurg Psychiatry 1984;47: 976–982.

    PubMed  Google Scholar 

  26. Strauss MH, Reeves RA, Smith DL, Leenen FHH. The role of the cardiac beta-1 receptors in the hemodynamic response to a beta-2 agonist.Clin Pharmacol Ther 1986;40: 108–115.

    PubMed  Google Scholar 

  27. Leenen FHH, Chan YK, Smith DL, Reeves RA. Epinephrine and left ventricular function in humans: effects of beta-1 vs nonselective beta-blockade.Clin Pharmacol Ther 1988;43: 519–528.

    PubMed  Google Scholar 

  28. Brodde OE, Daul A, Wellstein A, Palm D, Michel MC, Beckeringh JJ. Differentiation of beta-1- and beta-2-adrenoceptor-mediated effects in humans.Am J Physiol 1988;254: H199-H206.

    PubMed  Google Scholar 

  29. Motomura S, Zerkowski HR, Daul A, Brodde OE. On the physiologic role of beta-2 adrenoceptors in the human heart:in vitro andin vivo studies.Am Heart J 1990;119: 608–619.

    PubMed  Google Scholar 

  30. Conway FJ, Fitzgerald JD, McAinsh J, Rowlands DJ, Simpson WT. Human pharmacokinetic and pharmacodynamic studies on atenolol (ICI 66,082), a new cardioselectiveβ-adrenoceptor blocking drug.Br J Clin Pharmacol 1976;3: 267–272.

    PubMed  Google Scholar 

  31. De Plaen JF, Amery A, Reybrouck T. Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.Eur J Clin Pharmacol 1976;10: 297–303.

    PubMed  Google Scholar 

  32. Gugler R, Krist R, Raczinski H, Hoffgen K, Bodem G. Comparative pharmacodynamics and plasma levels ofβ-adrenoceptor blocking drugs.Br J Clin Pharmacol 1980;10: 337–343.

    PubMed  Google Scholar 

  33. Brown JE, McLeod AA, Shand DG. Evidence for cardiacβ 2-adrenoceptors in man.Clin Pharmacol Ther 1983;33: 424–428.

    PubMed  Google Scholar 

  34. Brown JE, McLeod AA, Shand DG. In support of cardiac chronotropic beta2-adrenoceptors.Am J Cardiol 1986;57: 11F-16F.

    PubMed  Google Scholar 

  35. Tattersfield AE, Cragg DJ. Effect of ICI 118,551 on bronchialβ-adrenoceptor function and exercise heart rate in normal man.Br J Clin Pharmacol 1983;16: 587–590.

    PubMed  Google Scholar 

  36. Arnold JMO, O'Connor PC, Riddell JG, Harron DWG, Shanks RG, McDevitt DG. Effectsβ 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-inducedβ-adrenoceptor responses in man.Br J Clin Pharmacol 1985;19: 619–630.

    PubMed  Google Scholar 

  37. Leenen FHH, Coenen CHM, Zonderland M, Maas AHJ. Effects of cardioselective and non-cardioselective beta-blockade on dynamic exercise performance in mildly hypertensive men.Clin Pharmacol Ther 1990;28: 12–21.

    Google Scholar 

  38. Benson MK, Berrill WT, Decalmer PB, Sterling GM, Chatterjee SS, Croxson RS, Cruickshank JM. Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease.Postgrad Med J 1977;53: 143S-148S.

    Google Scholar 

  39. Decalmer PBS, Chatterjee SS, Cruickshank JM, Benson MK, Sterling GM. Beta-blockers and asthma.Br Heart J 1978;40: 184–189.

    PubMed  Google Scholar 

  40. Ellis ME, Sahay JN, Chatterjee SS, Cruickshank JM, Ellis SH. Cardioselectivity of atenolol in asthmatic patients.Eur J Clin Pharmacol 1981;21: 173–176.

    PubMed  Google Scholar 

  41. Rahman MA, Bennett T. The effects of propranolol or atenolol on the cardiovascular responses to central hypovolaemia in Europeans and Bengalees.Br J Clin Pharmacol 1990;29: 69–77.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nyarko-Adomfeh, C. Cardiacβ 2-adrenoceptors and the inotropic response to exercise in man. Clinical Autonomic Research 1, 317–321 (1991). https://doi.org/10.1007/BF01819838

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01819838

Key words

Navigation